About Dash Pharmaceuticals
Dash Pharmaceuticals is a Healthcare company based in Upper Saddle River (United States) founded in 2014 by Julie Trendowicz, David Rosen, and Nick DiMaio, and was acquired by Natco Pharma in December 2021. Advanced spectroscopic and laser instrumentation is developed for industrial applications. Its chief executive, as recorded, is David Rosen. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified.
Company details
Developer of advanced spectroscopic and laser-based instrumentation. It designs and manufactures spectrometers and laser systems for various industrial applications, including nuclear decommissioning, high-value manufacturing, pharmaceuticals, and biopharmaceuticals. The companys technology, originally developed for space applications, enables highly sensitive measurement and identification of substances in challenging environments. Its offerings include Raman spectrometers, miniature spectrometers, and bespoke LIDAR solutions. It also provides in-house sampling services and expertise in FabryPérot interferometry. The firm collaborates with industry and academia to develop innovative solutions for complex analytical challenges.
- Headquarters Upper Saddle River, United States
- Founders Julie Trendowicz, David Rosen, Nick DiMaio
- Stage Acquired
- SectorsHealthcare
- Website dashpharm.com
- Social LinkedIn
- Acquired by Natco Pharma (Dec 2021)
- Investors
- Acquired byNatco Pharma
(Dec 2021)
Investors in Dash Pharmaceuticals
Dash Pharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Natco Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
APIs and finished dosage forms are developed and manufactured. | 1981 | natcopharma.co.in | Hyderabad, India |
Investor details for Dash Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Dash Pharmaceuticals
3 people are tracked at Dash Pharmaceuticals (3 in leadership).
| Name | Role | Group |
|---|---|---|
Julie Trendowicz | Co-Founder & VP | Leadership |
David Rosen | Co-Founder & CEO | Leadership |
Nick DiMaio | Co-Founder & President | Leadership |
Complete people profiles for Dash Pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Dash Pharmaceuticals
2 dated milestones of Dash Pharmaceuticals across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Dash Pharmaceuticals is founded.
- Exit Acquired by Natco Pharma.
Web traffic of Dash Pharmaceuticals
Websites that share an audience with Dash Pharmaceuticals (dashpharm.com).
Websites whose visitors overlap most with Dash Pharmaceuticals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| google.com | 100% | 85.8B | #1 | View details |
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Dash Pharmaceuticals (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | USD 3.02 B | 8,300 | ||
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Dash Pharmaceuticals
Dash Pharmaceuticals was founded in 2014.
Dash Pharmaceuticals is headquartered in Upper Saddle River, United States. It is registered at Upper Saddle River, New Jersey, United States.
David Rosen is the CEO of Dash Pharmaceuticals, as recorded in our data. They have also founded this company.
Developer of advanced spectroscopic and laser-based instrumentation. It designs and manufactures spectrometers and laser systems for various industrial applications, including nuclear decommissioning, high-value manufacturing, pharmaceuticals, and biopharmaceuticals. The companys technology, originally developed for space applications, enables highly sensitive measurement and identification of substances in challenging environments. Its offerings include Raman spectrometers, miniature spectrometers, and bespoke LIDAR solutions. It also provides in-house sampling services and expertise in FabryPérot interferometry. The firm collaborates with industry and academia to develop innovative solutions for complex analytical challenges.
Dash Pharmaceuticals has 1 investor. Key investors include Natco Pharma.
Yes. Dash Pharmaceuticals was acquired by Natco Pharma in December 2021.
